| MPS Pharmaa Ltd | 8.01 Cr. | 4.19 | 4.33/2.92 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,426 Cr. | 314 | 390/196 | 65.0 | 20.5 | 0.21 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 60.0 Cr. | 80.9 | 94.9/27.0 | 23.0 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 38.1 Cr. | 26.0 | 27.5/8.74 | 49.5 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 84.9 Cr. | 113 | 155/87.0 | 12.7 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 350 Cr. | 15.4 | 29.0/13.2 | 20.2 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 332 Cr. | 708 | 1,054/635 | 18.8 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 79.0 Cr. | 26.3 | 26.3/14.6 | | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,176 Cr. | 400 | 440/145 | 143 | 98.6 | 0.31 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.09 Cr. | 29.0 | 43.8/23.6 | 122 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 17.4 Cr. | 7.00 | 15.4/6.95 | 38.7 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 262 Cr. | 270 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,750 Cr. | 1,321 | 1,584/970 | 80.5 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
| Murae Organisor Ltd | 179 Cr. | 1.93 | 3.03/1.03 | 242 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 36.0 Cr. | 15.0 | 16.4/6.40 | 43.4 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.0 Cr. | 14.8 | 24.6/14.4 | 18.0 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 279 Cr. | 781 | 999/345 | 12.0 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.8 Cr. | 37.8 | 49.0/30.6 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
| Colinz Laboratories Ltd | 24.3 Cr. | 53.1 | 84.4/36.0 | 44.1 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 8.17 Cr. | 3.27 | 26.5/2.97 | 32.7 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.7 Cr. | 91.4 | 154/52.2 | 11.0 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 5.65 Cr. | 10.3 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 51.3 Cr. | 68.0 | 148/63.0 | 32.5 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 5.64 Cr. | 18.8 | 27.8/14.6 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,236 Cr. | 591 | 624/324 | 58.6 | 53.3 | 0.17 % | 30.0 % | 22.4 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 112 Cr. | 25.9 | 42.0/22.2 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 18.2 Cr. | 35.8 | 46.0/22.2 | 53.4 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 191 Cr. | 331 | 418/226 | 19.6 | 110 | 1.36 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 25.5 Cr. | 43.4 | 62.6/7.03 | 73.0 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 72,974 Cr. | 1,245 | 1,593/958 | 20.0 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 162 Cr. | 259 | 307/131 | 26.2 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,038 Cr. | 208 | 265/162 | 17.6 | 60.5 | 1.20 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 54.2 Cr. | 41.5 | 75.0/40.1 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
| Ami Organics Ltd | 8,255 Cr. | 2,022 | 2,396/1,004 | 88.4 | 294 | 0.15 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 6.74 Cr. | 1.02 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 382 Cr. | 49.8 | 77.7/39.2 | 28.7 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 11.2 Cr. | 19.1 | 28.7/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 91.9 Cr. | 3.90 | 6.25/2.87 | 139 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 59,242 Cr. | 27,850 | 30,683/24,869 | 46.1 | 1,657 | 1.47 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,784 Cr. | 638 | 722/381 | 25.4 | 205 | 0.47 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 144 Cr. | 49.8 | 75.8/37.0 | 20.8 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,627 Cr. | 959 | 1,060/440 | | 58.0 | 0.10 % | 7.32 % | 16.8 % | 10.0 |
| Wockhardt Ltd | 23,269 Cr. | 1,430 | 1,583/420 | | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
| Wanbury Ltd | 796 Cr. | 241 | 325/122 | 28.8 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
| Venus Remedies Ltd | 391 Cr. | 294 | 428/280 | 17.7 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 4,903 Cr. | 698 | 950/433 | 98.0 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 1,850 Cr. | 1,302 | 1,923/1,232 | 28.6 | 735 | 0.77 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,10,459 Cr. | 3,264 | 3,591/2,414 | 63.5 | 222 | 0.86 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,310 Cr. | 251 | 317/181 | 43.6 | 44.8 | 0.20 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,728 Cr. | 18.4 | 27.9/11.0 | 54.4 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 26,370 Cr. | 1,036 | 1,360/585 | 109 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,673 Cr. | 122 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,40,175 Cr. | 1,834 | 1,960/1,348 | 39.3 | 288 | 0.74 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,932 Cr. | 679 | 886/322 | | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
| SMS Pharmaceuticals Ltd | 1,777 Cr. | 211 | 398/120 | 30.3 | 70.6 | 0.19 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 365 Cr. | 1,207 | 1,750/538 | 18.0 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,956 Cr. | 813 | 960/316 | 139 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,424 Cr. | 177 | 241/91.8 | 208 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 12,350 Cr. | 5,360 | 7,600/4,606 | 29.3 | 298 | 3.12 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,582 Cr. | 2,163 | 2,977/1,360 | 41.1 | 229 | 0.74 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,156 Cr. | 5,512 | 5,850/4,637 | 40.4 | 324 | 1.09 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 263 Cr. | 74.5 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
| Pfizer Ltd | 21,852 Cr. | 4,785 | 6,453/3,950 | 35.7 | 820 | 0.73 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 246 Cr. | 200 | 348/180 | 13.5 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,344 Cr. | 382 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 7,792 Cr. | 1,535 | 1,998/710 | 65.5 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,753 Cr. | 13,858 | 18,100/5,532 | 67.2 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 882 Cr. | 39.3 | 56.5/26.2 | 82.2 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 23,313 Cr. | 1,301 | 1,639/828 | 12.0 | 399 | 0.73 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 3,623 Cr. | 66.1 | 101/38.6 | 27.6 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 11,531 Cr. | 254 | 359/126 | 33.3 | 50.3 | 0.24 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 164 Cr. | 102 | 145/85.2 | 17.4 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 555 Cr. | 155 | 177/97.9 | 175 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 98,170 Cr. | 2,151 | 2,403/1,436 | 37.4 | 343 | 0.37 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,498 Cr. | 746 | 980/498 | 15.5 | 319 | 0.24 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 31,516 Cr. | 585 | 620/359 | 134 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 921 Cr. | 888 | 1,070/405 | 26.8 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 220 Cr. | 104 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
| Kopran Ltd | 975 Cr. | 205 | 370/187 | 18.4 | 103 | 1.46 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 532 Cr. | 330 | 470/298 | 37.9 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 15,272 Cr. | 958 | 1,310/538 | 53.7 | 373 | 0.52 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,112 Cr. | 1,806 | 2,030/1,474 | 46.0 | 207 | 0.68 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,691 Cr. | 255 | 328/108 | 46.4 | 29.7 | 0.78 % | 17.0 % | 13.0 % | 2.00 |
| Ipca Laboratories Ltd | 40,191 Cr. | 1,584 | 1,758/1,052 | 64.5 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,270 Cr. | 387 | 538/331 | 22.6 | 283 | 1.29 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 126 Cr. | 23.4 | 34.7/14.3 | 2.30 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 682 Cr. | 115 | 186/86.2 | 6.68 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 2,659 Cr. | 289 | 388/281 | | 118 | 0.52 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,531 Cr. | 367 | 465/260 | 61.7 | 97.6 | 0.33 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 1,840 Cr. | 2,172 | 3,379/1,293 | 78.4 | 355 | 0.28 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,334 Cr. | 432 | 504/278 | 51.0 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 14,549 Cr. | 600 | 725/382 | 29.9 | 141 | 0.25 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 42,641 Cr. | 1,511 | 1,831/767 | | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 35,300 Cr. | 2,088 | 3,088/1,825 | 44.0 | 98.7 | 1.53 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 26,769 Cr. | 1,622 | 2,221/1,586 | 24.3 | 557 | 1.23 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 7,659 Cr. | 470 | 659/405 | 24.2 | 141 | 1.06 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 16,942 Cr. | 1,247 | 1,594/809 | 48.8 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,586 Cr. | 1,289 | 1,421/1,120 | 20.1 | 369 | 0.62 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,703 Cr. | 236 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
| Cipla Ltd | 1,17,205 Cr. | 1,451 | 1,702/1,312 | 25.4 | 351 | 0.90 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 16,836 Cr. | 2,215 | 2,641/1,221 | 34.1 | 334 | 0.23 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 430 Cr. | 162 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,732 Cr. | 164 | 186/92.2 | 19.6 | 96.0 | 0.30 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 89.8 Cr. | 55.4 | 92.0/53.0 | 169 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 47,724 Cr. | 397 | 405/244 | 33.1 | 175 | 0.13 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,837 Cr. | 1,910 | 2,326/1,060 | 44.8 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 176 Cr. | 111 | 158/89.0 | 23.1 | 43.2 | 1.08 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 194 Cr. | 82.0 | 113/73.2 | 252 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 17,661 Cr. | 7,076 | 8,140/4,050 | 137 | 272 | 0.34 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,039 Cr. | 702 | 863/570 | 42.9 | 103 | 0.66 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 263 Cr. | 125 | 145/69.9 | 12.6 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 61,976 Cr. | 5,184 | 6,440/4,407 | 28.5 | 961 | 0.77 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 19,214 Cr. | 978 | 1,304/823 | 30.2 | 249 | 1.12 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 709 Cr. | 1,240 | 1,754/1,010 | 10.4 | 724 | 0.93 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 36,243 Cr. | 2,896 | 3,486/1,998 | 41.4 | 294 | 1.24 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,731 Cr. | 334 | 571/325 | 25.4 | 120 | 1.53 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 3,813 Cr. | 414 | 635/408 | 30.5 | 126 | 0.24 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 14,523.37 | N/A | | 42.93 | N/A | N/A | 16.05 | 15.89 | N/A |
